Blog
Kingsley Napley’s Medical Negligence Team ‘walks together’ with the Dame Vera Lynn Children’s Charity
Sharon Burkill
29 May 2019
Victim Impact Statement for Business: your opportunity to be heard
We often act for businesses who have been the victims of crime. The Code of Practice for Victims of Crime (‘the Victims’ Code’) allows an opportunity for the voice of the business to be heard by way of an Impact Statement for Business (ISB).
28 May 2019
New ICAEW sanctions guidance on criminal convictions, cautions and Anti-Money Laundering
From 1 April 2019, criminal conduct by ICAEW members will be dealt with according to the new version of the Guidance on Sanctions, which simplifies as well as amplifies the 2018 version.
Further changes will follow in July 2019, with the introduction of new guidance for Anti-Money Laundering breaches where the relevant conduct has not resulted in a criminal conviction.
22 May 2019
“Flatly against the public interest”: The gravity of a lack of candour during investigations
PSA v NMC and Another [2019] EWHC 1181 (Admin)
The High Court has quashed a three year caution imposed on a registered nurse who dishonestly covered up her failings in relation to a suicidal patient, including in the inquest into the patient’s death, following a successful appeal by the Professional Standards Authority (PSA) for Health and Social Care.
The case is an illustration of the importance of being candid in investigations, and the seriousness of attempts to cover-up of clinical failings, even where those clinical failings have subsequently been adequately remediated.
25 April 2019
Identity Fraud: company directors at double the risk of other individuals
Company directors increasingly have to deal with personal identity theft on top of already substantial compliance requirements to meet their directors’ duties. The risk of identity theft is even greater for those company directors based in London than in other areas of the United Kingdom.
25 April 2019
Confused, Bewildering, Dubious? Cannabidiol in food and drinks: What does the future hold?
Last October, the EU Novel Foods Committee met to consider the evidence on certain hemp derived products, including Cannabidiol [CBD], to evaluate whether they had been widely used for human consumption within the EU prior to the 15th of May 1997, that being the date upon which the original “Novel Food” regulation, (EC) 258/97 came into force.